Vlado Perkovic

Summary

Publications

  1. ncbi request reprint Treatment of renovascular disease with percutaneous stent insertion: long-term outcomes
    V Perkovic
    Department of Nephrology, Royal Melbourne Hospital, Melbourne, Australia
    Australas Radiol 45:438-43. 2001
  2. ncbi request reprint Accelerated progression of calcific aortic stenosis in dialysis patients
    Vlado Perkovic
    Department of Nephrology, Royal Melbourne Hospital, Parkville, Vic, Australia
    Nephron Clin Pract 94:c40-5. 2003
  3. doi request reprint Interventions for erythropoietin-resistant anaemia in dialysis patients
    Sunil V Badve
    Department of Nephrology, Princess Alexandra Hospital, Woolloongabba, QLD, Australia, 4102
    Cochrane Database Syst Rev 8:CD006861. 2013
  4. pmc Mortality in dialysis patients may not be associated with ESA dose: a 2-year prospective observational study
    Lawrence P McMahon
    Monash University, Melbourne, Australia
    BMC Nephrol 13:40. 2012
  5. doi request reprint The rationale and design of the Beta-blocker to LOwer CArdiovascular Dialysis Events (BLOCADE) Feasibility Study
    Matthew A Roberts
    Department of Renal Medicine, Eastern Health Clinical School, Monash University, Melbourne, Victoria, Australia
    Nephrology (Carlton) 20:140-7. 2015
  6. doi request reprint Prospective evaluation of aortic stenosis in end-stage kidney disease: a more fulminant process?
    Dominica Zentner
    1Department of Cardiology, Royal Melbourne Hospital, Melbourne VIC, Australia
    Nephrol Dial Transplant 26:1651-5. 2011
  7. doi request reprint Effects of uric acid-lowering therapy on renal outcomes: a systematic review and meta-analysis
    Bhadran Bose
    Department of Nephrology, University of Queensland at Princess Alexandra Hospital, Brisbane, Australia
    Nephrol Dial Transplant 29:406-13. 2014
  8. doi request reprint Phosphate in early chronic kidney disease: associations with clinical outcomes and a target to reduce cardiovascular risk
    Nigel D Toussaint
    The Royal Melbourne Hospital, Grattan Street, Parkville, VIC 3052, Australia
    Nephrology (Carlton) 17:433-44. 2012
  9. pmc Socioeconomic disadvantage and kidney disease in the United States, Australia, and Thailand
    Sarah L White
    George Institute, Sydney, NSW, Australia
    Am J Public Health 98:1306-13. 2008
  10. pmc Effects of statins in patients with chronic kidney disease: meta-analysis and meta-regression of randomised controlled trials
    Giovanni F M Strippoli
    NHMRC Centre for Clinical Research Excellence in Renal Medicine, School of Public Health, University of Sydney, Australia
    BMJ 336:645-51. 2008

Detail Information

Publications12

  1. ncbi request reprint Treatment of renovascular disease with percutaneous stent insertion: long-term outcomes
    V Perkovic
    Department of Nephrology, Royal Melbourne Hospital, Melbourne, Australia
    Australas Radiol 45:438-43. 2001
    ..Restenosis was common after 6 months, occurring eventually in 29% of screened patients, but was not shown to affect clinical outcomes. Insertion of renal artery stents is a safe and effective treatment for renal artery stenosis...
  2. ncbi request reprint Accelerated progression of calcific aortic stenosis in dialysis patients
    Vlado Perkovic
    Department of Nephrology, Royal Melbourne Hospital, Parkville, Vic, Australia
    Nephron Clin Pract 94:c40-5. 2003
    ..Little data exist on the rate at which aortic stenosis progresses in this patient group...
  3. doi request reprint Interventions for erythropoietin-resistant anaemia in dialysis patients
    Sunil V Badve
    Department of Nephrology, Princess Alexandra Hospital, Woolloongabba, QLD, Australia, 4102
    Cochrane Database Syst Rev 8:CD006861. 2013
    ..However, about 5% to 10% of patients with ESKD exhibit resistance to ESAs, and observational studies have shown that patients requiring high doses of ESA are at increased risk of mortality...
  4. pmc Mortality in dialysis patients may not be associated with ESA dose: a 2-year prospective observational study
    Lawrence P McMahon
    Monash University, Melbourne, Australia
    BMC Nephrol 13:40. 2012
    ..Nonetheless, a causative role has not been demonstrated, and this potential relationship requires further appraisal in such a complex patient group...
  5. doi request reprint The rationale and design of the Beta-blocker to LOwer CArdiovascular Dialysis Events (BLOCADE) Feasibility Study
    Matthew A Roberts
    Department of Renal Medicine, Eastern Health Clinical School, Monash University, Melbourne, Victoria, Australia
    Nephrology (Carlton) 20:140-7. 2015
    ....
  6. doi request reprint Prospective evaluation of aortic stenosis in end-stage kidney disease: a more fulminant process?
    Dominica Zentner
    1Department of Cardiology, Royal Melbourne Hospital, Melbourne VIC, Australia
    Nephrol Dial Transplant 26:1651-5. 2011
    ..Our aim was to determine whether the increased rate of progression resulted in shorter major event-free (AVR or death) survival as compared to controls...
  7. doi request reprint Effects of uric acid-lowering therapy on renal outcomes: a systematic review and meta-analysis
    Bhadran Bose
    Department of Nephrology, University of Queensland at Princess Alexandra Hospital, Brisbane, Australia
    Nephrol Dial Transplant 29:406-13. 2014
    ..The aim of this systematic review is to summarize evidence from randomized controlled trials (RCTs) concerning the benefits and risks of uric acid-lowering therapy on renal outcomes...
  8. doi request reprint Phosphate in early chronic kidney disease: associations with clinical outcomes and a target to reduce cardiovascular risk
    Nigel D Toussaint
    The Royal Melbourne Hospital, Grattan Street, Parkville, VIC 3052, Australia
    Nephrology (Carlton) 17:433-44. 2012
    ..This review outlines the epidemiological and experimental evidence highlighting the relationship between excess phosphate and adverse outcomes, and discusses clinical studies required to address this problem...
  9. pmc Socioeconomic disadvantage and kidney disease in the United States, Australia, and Thailand
    Sarah L White
    George Institute, Sydney, NSW, Australia
    Am J Public Health 98:1306-13. 2008
    ..We sought to determine whether an elevated burden of chronic kidney disease is found among disadvantaged groups living in the United States, Australia, and Thailand...
  10. pmc Effects of statins in patients with chronic kidney disease: meta-analysis and meta-regression of randomised controlled trials
    Giovanni F M Strippoli
    NHMRC Centre for Clinical Research Excellence in Renal Medicine, School of Public Health, University of Sydney, Australia
    BMJ 336:645-51. 2008
    ..To analyse the benefits and harms of statins in patients with chronic kidney disease (pre-dialysis, dialysis, and transplant populations)...
  11. ncbi request reprint Chronic kidney disease, cardiovascular events, and the effects of perindopril-based blood pressure lowering: data from the PROGRESS study
    Vlado Perkovic
    George Institute for International Health, PO Box M201, Sydney, Australia, 2050
    J Am Soc Nephrol 18:2766-72. 2007
    ..In conclusion, kidney function should be considered when determining the need for blood pressure lowering therapy in patients with cerebrovascular disease...
  12. ncbi request reprint The CARI guidelines. Dialysis adequacy (HD) guidelines
    Peter Kerr
    Nephrology (Carlton) 10:S61-80. 2005